VLKIM
MDT icon

Van Lanschot Kempen Investment Management’s Medtronic MDT Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.6M Buy
633,450
+254,497
+67% +$20.5M 0.38% 43
2026
Q1 		$32.8M Buy
378,953
+19,231
+5% +$1.84M 0.29% 65
2025
Q4 		$34.6M Buy
359,722
+8,013
+2% +$778K 0.3% 53
2025
Q3 		$33.5M Buy
351,709
+8,355
+2% +$768K 0.3% 58
2025
Q2 		$29.9M Sell
343,354
-1,759,696
-84% -$149M 0.29% 65
2025
Q1 		$189M Buy
2,103,050
+228,316
+12% +$20.4M 1.97% 12
2024
Q4 		$150M Buy
1,874,734
+234,629
+14% +$20.3M 1.49% 16
2024
Q3 		$148M Buy
1,640,105
+74,827
+5% +$6.29M 1.51% 14
2024
Q2 		$123M Buy
1,565,278
+68,039
+5% +$5.58M 1.38% 16
2024
Q1 		$130M Buy
1,497,239
+101,670
+7% +$8.68M 1.62% 11
2023
Q4 		$115M Buy
1,395,569
+61,500
+5% +$4.69M 1.6% 12
2023
Q3 		$105M Buy
1,334,069
+126,583
+10% +$10.6M 1.93% 10
2023
Q2 		$106M Buy
1,207,486
+63,475
+6% +$5.46M 1.92% 10
2023
Q1 		$92.2M Buy
1,144,011
+601,610
+111% +$49M 1.75% 9
2022
Q4 		$42.2M Buy
542,401
+443,246
+447% +$35.9M 1.23% 29
2022
Q3 		$8.01M Buy
99,155
+1,074
+1% +$96.5K 0.32% 92
2022
Q2 		$8.8M Buy
98,081
+3,875
+4% +$393K 0.32% 92
2022
Q1 		$10.5M Buy
94,206
+4,483
+5% +$474K 0.32% 89
2021
Q4 		$9.28M Buy
89,723
+8,210
+10% +$951K 0.29% 94
2021
Q3 		$10.2M Buy
81,513
+6,069
+8% +$786K 0.37% 89
2021
Q2 		$9.12M Buy
75,444
+20,950
+38% +$2.63M 0.33% 90
2021
Q1 		$6.44M Buy
54,494
+4,502
+9% +$528K 0.3% 87
2020
Q4 		$5.86M Buy
49,992
+11,052
+28% +$1.22M 0.34% 89
2020
Q3 		$4.05M Sell
38,940
-3,239
-8% -$325K 0.31% 89
2020
Q2 		$3.87M Buy
42,179
+2,308
+6% +$221K 0.28% 92
2020
Q1 		$3.6M Buy
39,871
+11,300
+40% +$1.2M 0.3% 89
2019
Q4 		$3.24M Sell
28,571
-14,360
-33% -$1.58M 0.2% 96
2019
Q3 		$4.66M Buy
42,931
+16,531
+63% +$1.72M 0.37% 82
2019
Q2 		$2.57M Sell
26,400
-100
-0.4% -$9.13K 0.22% 96
2019
Q1 		$2.41M Sell
26,500
-2,300
-8% -$206K 0.22% 100
2018
Q4 		$2.62M Buy
+28,800
New +$2.69M 0.29% 92

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Van Lanschot Kempen Investment Management's MDT Position: Q2 2026 in Review

Van Lanschot Kempen Investment Management increased its Medtronic (MDT) stake by 67% in Q2 2026, buying an estimated $20.5M and bringing the position to 633,450 shares worth $49.6M. The position accounts for 0.38% of the portfolio, ranked #43.

Van Lanschot Kempen Investment Management first reported a position in MDT in Q4 2018 and has held it in 31 quarters since. The position peaked at $189M in Q1 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Van Lanschot Kempen Investment Management held 633,450 shares of Medtronic worth $49.6M as of Q2 2026.
  • Van Lanschot Kempen Investment Management bought 254,497 Medtronic shares in Q2 2026, an estimated $20.5M.
  • Medtronic made up 0.38% of Van Lanschot Kempen Investment Management's portfolio in Q2 2026, its #43 holding.
  • Van Lanschot Kempen Investment Management first reported a position in Medtronic in Q4 2018 and has held it in 31 quarters since.
  • Van Lanschot Kempen Investment Management's Medtronic position peaked at $189M in Q1 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.